AveXis Inc (AVXS1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Sean P. Nolan
Employees:
10,200
2275 HALF DAY ROAD, SUITE 160, BANNOCKBURN, IL 60015
972-725-7797

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

AveXis, Inc. operates as a clinical-stage gene therapy company that engages in the research and development of technology specifically for neurological genetic disease treatment. Its proprietary gene therapy candidate, AVXS-101 has been granted orphan drug designation for the treatment of all types of spinal muscular atrophy and fast track designation for the treatment of spinal muscular atrophy type 1. The company was founded by John D. Harkey, Jr. in 2010 and is headquartered in Chicago, IL.

Data derived from most recent annual or quarterly report
Market Cap 8.02 Billion Shares Outstanding36.816 Million Avg 30-day Volume 988.011 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-6.2
Price to Revenue0.0 Debt to Equity0.0 EBITDA-409.565 Million
Price to Book Value7.9915 Operating Margin0.0 Enterprise Value3.96 Billion
Current Ratio8.217 EPS Growth-2.546 Quick Ratio8.058
1 Yr BETA 1.1322 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth-323.375 Altman Z-Score25.5595 Free Cash Flow to Firm -251.431 Million
View SEC Filings from AVXS1 instead.

View recent insider trading info

Funds Holding AVXS1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVXS1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOVARTIS AG

  • 10% Owner
36,816,476 2018-05-15 0

LITALIEN JAMES J SRVP/CHIEF REG&QUALITY OFFICER

  • Officer
No longer subject to file 2018-05-15 0

WELCH DANIEL G

  • Director
No longer subject to file 2018-05-15 0

DONENBERG PHILLIP B. CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2018-05-15 0

KEARNEY TERRENCE C

  • Director
No longer subject to file 2018-05-15 0

MANNING PAUL B

  • Director
  • FORMER 10% OWNER
No longer subject to file 2018-05-15 0

SIFFERT JOAO MD

  • Director
No longer subject to file 2018-05-15 0

VERWIEL FRANK

  • Director
No longer subject to file 2018-05-15 0

NOLAN SEAN P. PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2018-05-15 0

KOH BONG Y

  • Director
No longer subject to file 2018-05-15 0

MODI RICK CHIEF BUSINESS OFFICER

  • Officer
No longer subject to file 2018-05-15 0

NAGENDRAN SUKUMAR SR. VP & CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2018-05-15 0

KNUDTEN ANDREW F. SRVP/MANUFACTURE&SUPPLY CHAIN

  • Officer
No longer subject to file 2018-05-15 0

KASPAR BRIAN K. CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
No longer subject to file 2018-05-15 0

JOHANNESEN MICHAEL GENERAL COUNSEL

  • Officer
No longer subject to file 2018-05-15 0

SESSION R.A. II SR. VP, CORP STRATEGY

  • Officer
No longer subject to file 2018-05-15 0

SMITH LORI J. SVP-CHIEF HUMAN RESOURCE OFF.

  • Officer
No longer subject to file 2018-05-15 0

DEE THOMAS J. SR. VP & CFO

  • Officer
0 2017-05-10 0

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
210,000 2016-02-17 0

MANNING PAUL B

PBM CAPITAL INVESTMENTS, LLC

  • Director
  • FORMER 10% OWNERFORMER 10% OWNER
1,912,176 2016-02-17 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • Director
  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
131,911 2016-02-10 0

FLYNN JAMES E

DEERFIELD MANAGEMENT CO

  • Director
  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
0 2016-02-10 0

LEFF JONATHAN S

  • Director
0 2016-02-10 0

NUECHTERLEIN CAROLE

  • Director
0 2016-02-10 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PARTNERS, LP

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • Director
  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
2,236,700 2015-09-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments